Safety and efficacy of lixisenatide vs sulfonylurea added to basal insulin in patients with type 2 diabetes who fast during Ramadan (LixiRam): a randomised controlled trial

被引：0
|
作者：
Hassanein, M. M. [1 ]
Hafidh, K. [2 ]
Shehadeh, N. [3 ]
Azar, S. [4 ]
Hanif, W. [5 ]
Li, H. [6 ]
Djaballah, K. [7 ]
Sahay, R. [8 ]
机构：
[1] Dubai Hosp, Dubai, U Arab Emirates
[2] Rashid Hosp, Dubai, U Arab Emirates
[3] Rambam Med Ctr, Haifa, Israel
[4] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
[5] Univ Hosp Birmingham, Birmingham, W Midlands, England
[6] Sanofi Aventis China, Beijing, Peoples R China
[7] Sanoti, Paris, France
[8] Osmania Med Coll & Hosp, Hyderabad, Telangana, India
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
757
引用
收藏
页码：S371 / S371
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of sitagliptin added to treatment of patients with type 2 diabetes inadequately controlled with premixed insulin
    Yu, Miao
    Shankar, R. Ravi
    Zhang, Ruya
    Zhang, Ye
    Lin, Jianxin
    O'Neill, Edward A.
    Chen, Guojuan
    Liu, Shu
    Tu, Yingmei
    Engel, Samuel S.
    DIABETES OBESITY & METABOLISM, 2019, 21 (02): : 408 - 411
  • [22] Efficacy and Safety of Sitagliptin Added to Insulin in Japanese Patients with Type 2 Diabetes: The EDIT Randomized Trial
    Sato, Seiji
    Saisho, Yoshifumi
    Kou, Kinsei
    Meguro, Shu
    Tanaka, Masami
    Irie, Junichiro
    Kawai, Toshihide
    Itoh, Hiroshi
    PLOS ONE, 2015, 10 (03):
  • [23] Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial
    Fulcher, Greg
    Matthews, David R.
    Perkovic, Vlado
    de Zeeuw, Dick
    Mahaffey, Kenneth W.
    Weiss, Robert
    Rosenstock, Julio
    Capuano, George
    Desai, Mehul
    Shaw, Wayne
    Vercruysse, Frank
    Meininger, Gary
    Neal, Bruce
    DIABETES THERAPY, 2015, 6 (03) : 289 - 302
  • [24] Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial
    Greg Fulcher
    David R. Matthews
    Vlado Perkovic
    Dick de Zeeuw
    Kenneth W. Mahaffey
    Robert Weiss
    Julio Rosenstock
    George Capuano
    Mehul Desai
    Wayne Shaw
    Frank Vercruysse
    Gary Meininger
    Bruce Neal
    Diabetes Therapy, 2015, 6 : 289 - 302
  • [25] COMPARATIVE EFFICACY AND SAFETY OF LIXISENATIDE AND INSULIN REGIMENS IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED BY BASAL INSULIN: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Men, P.
    Qu, S.
    Luo, W.
    Liu, Y.
    Li, C.
    Zhai, S.
    VALUE IN HEALTH, 2018, 21 : S35 - S35
  • [26] Efficacy and safety of lixisenatide in Japanese patients with type 2 diabetes mellitus inadequately controlled by sulfonylurea with or without metformin: Subanalysis of GetGoal-S
    Onishi, Yukiko
    Niemoeller, Elisabeth
    Ikeda, Yukio
    Takagi, Hiroki
    Yabe, Daisuke
    Seino, Yutaka
    JOURNAL OF DIABETES INVESTIGATION, 2015, 6 (02) : 201 - 209
  • [27] Semaglutide Added to Basal Insulin in Type 2 Diabetes (SUSTAIN 5): A Randomized, Controlled Trial
    Rodbard, Helena W.
    Lingvay, Ildiko
    Reed, John
    de la Rosa, Raymond
    Rose, Ludger
    Sugimoto, Danny
    Araki, Eiichi
    Chu, Pei-Ling
    Wijayasinghe, Nelun
    Norwood, Paul
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (06): : 2291 - 2301
  • [28] Efficacy and Safety of Once-Daily Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Basal Insulin ± Metformin: GetGoal-L Study
    Riddle, Matthew
    Home, Philip
    Marre, Michel
    Niemoeller, Elisabeth
    Ping, Lin
    Rosenstock, Julio
    DIABETES, 2012, 61 : A251 - A251
  • [29] Efficacy and safety of once-daily lixisenatide in type 2 diabetes insufficiently controlled with basal insulin ± metformin: GetGoal-L study
    Aronson, R.
    Riddle, M.
    Home, P.
    Marre, M.
    Niemoeller, E.
    Ping, L.
    Rosenstock, J.
    DIABETOLOGIA, 2012, 55 : S8 - S8
  • [30] Efficacy and safety of liraglutide versus sulphonylurea both in combination with metformin during Ramadan in subjects with type 2 diabetes (LIRA-Ramadan): a randomised trial
    Azar, S.
    Echtay, A.
    Bebakar, W. Wan
    Al Araj, S.
    Berrah, A.
    Omar, M.
    Mutha, A.
    Tornoe, K.
    Kaltoft, M.
    Shehadeh, N.
    DIABETOLOGIA, 2015, 58 : S82 - S83
12345